Julie Rubinstein sold $948K of Adaptive Biotechnologies Corp (ADPT) stock

Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares of ADPT stock worth $948K, per an SEC Form 4 filed Oct 8, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 6, 2026, 2 days before it was made public.

ADPT has moved -3.0% since the trade date, from $26.90 to $26.09 (Oct 8, 2026 close).